Nu Skin Enterprises (NUS) Earns “Buy” Rating from Citigroup

Nu Skin Enterprises (NYSE:NUS)‘s stock had its “buy” rating restated by equities research analysts at Citigroup in a research report issued to clients and investors on Tuesday, Marketbeat.com reports. They currently have a $81.00 price target on the stock, up from their prior price target of $70.00. Citigroup’s price target would suggest a potential upside of 14.34% from the company’s current price.

A number of other analysts have also recently issued reports on the company. Zacks Investment Research cut Nu Skin Enterprises from a “hold” rating to a “sell” rating in a research note on Wednesday, December 20th. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and five have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $65.38.

Shares of Nu Skin Enterprises (NYSE NUS) traded up $0.85 during mid-day trading on Tuesday, hitting $70.84. The stock had a trading volume of 358,100 shares, compared to its average volume of 326,157. The company has a current ratio of 1.78, a quick ratio of 1.18 and a debt-to-equity ratio of 0.44. The company has a market cap of $3,800.00, a PE ratio of 25.95, a PEG ratio of 2.26 and a beta of 1.55. Nu Skin Enterprises has a one year low of $47.10 and a one year high of $71.00.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings results on Wednesday, November 1st. The company reported $0.76 EPS for the quarter, meeting analysts’ consensus estimates of $0.76. Nu Skin Enterprises had a return on equity of 22.38% and a net margin of 6.97%. The company had revenue of $563.70 million during the quarter, compared to analysts’ expectations of $562.70 million. During the same period in the prior year, the business posted $0.98 EPS. Nu Skin Enterprises’s revenue was down 6.7% on a year-over-year basis. analysts anticipate that Nu Skin Enterprises will post 3.24 EPS for the current year.

In other Nu Skin Enterprises news, insider Joseph Y. Chang sold 36,503 shares of the company’s stock in a transaction that occurred on Friday, November 10th. The stock was sold at an average price of $62.24, for a total transaction of $2,271,946.72. Following the completion of the transaction, the insider now owns 66,563 shares of the company’s stock, valued at approximately $4,142,881.12. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Chairman Steven Lund sold 13,978 shares of the company’s stock in a transaction that occurred on Friday, January 19th. The stock was sold at an average price of $70.01, for a total value of $978,599.78. Following the transaction, the chairman now directly owns 4,769 shares of the company’s stock, valued at approximately $333,877.69. The disclosure for this sale can be found here. Over the last three months, insiders have sold 257,645 shares of company stock valued at $17,367,125. 5.20% of the stock is owned by company insiders.

A number of large investors have recently added to or reduced their stakes in the business. Ameritas Investment Partners Inc. boosted its position in Nu Skin Enterprises by 2.0% during the 2nd quarter. Ameritas Investment Partners Inc. now owns 14,864 shares of the company’s stock worth $934,000 after acquiring an additional 297 shares during the last quarter. Suntrust Banks Inc. boosted its position in Nu Skin Enterprises by 3.8% during the 2nd quarter. Suntrust Banks Inc. now owns 8,426 shares of the company’s stock worth $529,000 after acquiring an additional 309 shares during the last quarter. Numeric Investors LLC boosted its position in Nu Skin Enterprises by 5.0% during the 2nd quarter. Numeric Investors LLC now owns 8,400 shares of the company’s stock worth $528,000 after acquiring an additional 400 shares during the last quarter. Nationwide Fund Advisors boosted its position in Nu Skin Enterprises by 0.6% during the 2nd quarter. Nationwide Fund Advisors now owns 84,553 shares of the company’s stock worth $5,313,000 after acquiring an additional 542 shares during the last quarter. Finally, Thrivent Financial For Lutherans boosted its position in Nu Skin Enterprises by 8.1% during the 2nd quarter. Thrivent Financial For Lutherans now owns 10,000 shares of the company’s stock worth $628,000 after acquiring an additional 750 shares during the last quarter. 77.52% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises (NUS) Earns “Buy” Rating from Citigroup” was posted by TrueBlueTribune and is the property of of TrueBlueTribune. If you are accessing this piece of content on another site, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.truebluetribune.com/2018/01/23/citigroup-analysts-give-nu-skin-enterprises-nus-a-81-00-price-target.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply